New Options & Strategies for CV Risk Reduction in Diabetes: What the Data Tell Us

This interactive CME symposium will address the complex interrelationship of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes.
2.00 available credits
This interactive CME symposium will address the complex interrelationship of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes.
2.00 available credits
Enroll in this meeting
June 07, 2019
06:30 PM - 09:00 PM PDT
InterContinental San Francisco
888 Howard Street, San Francisco, California, United States
https://www4.cmrreg.com/ada2019
Enrollment Fee
Free
  • Overview

    This 2-hour, highly interactive CME-certified symposium will feature a faculty of 3 leading international experts who will address the complex interrelationship of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes.

    To attend this meeting: Go to https://www4.cmrreg.com/ada2019 to register for the American Diabetes Association’s 79th Scientific Sessions and our Corporate Symposium. 

    If you have already registered for Scientific Sessions, log in as a Non-Member using your e-mail address or as a Member using your e-mail address or professional member ID # and zip code, and you will be able to add the Corporate Symposium to your existing registration. Select ‘Edit Registration’ and proceed through the registration pages to the Corporate Symposia. After making your selection, click 'Next Page' until you see your confirmation summary. You will receive a revised e-mail confirmation.

    If you have any questions regarding your registration, please contact the ADA Registration & Hotel Support Center at (866) 290-9910 (toll free US & Canada) or (415) 268-2086 (International) Monday-Friday, between the hours of 9 a.m. - 9 p.m. ET or send a message at http://ada.cmrushelp.com.

     

  • Program Schedule

    6:30 pm–7:00 pm             

    Registration & Buffet Dinner

     

     

     

     

    7:00 pm–7:15 pm

    Program Overview

     

     

     

     

    7:15 pm–7:35 pm

    New Cholesterol Guidelines: What You Should Know

     

     

     

     

    7:35 pm–7:55 pm

    Omega-3 Fatty Acids and Their Use in Patients with ASCVD

     

     

     

     

    7:55 pm–8:15 pm

    Roundup of Recent Clinical Trial Evidence to Reduce ASCVD Events

     

     

     

     

    8:15 pm–8:35 pm

    Panel Discussion and Q&A

     

     

     

     

    8:35 pm–8:50 pm

    Case-based Learning on Personalization of Care in Patients with Diabetes and High-risk ASCVD

     

     

      

    8:50 pm–9:00 pm

    Closing Comments

     

     

     

     

    9:00 pm

    Program Adjourns

     

       
  • Faculty

    Robert H. Eckel, MD, Chair
    Deepak L. Bhatt, MD, MPH
    Sergio Fazio, MD, PhD

  • Target Audience

    This activity is intended for Endocrinologists, Diabetologists, Cardiologists, Internists, NPs/PAs, and other healthcare providers engaged in the care of patients with diabetes.

  • Accreditation and Credit Designation

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Omnia-Prova Education Collaborative, Inc. (“TOPEC”) and Medtelligence. TOPEC is accredited by the ACCME to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this live activity for up to 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • Commercial Support

    This activity is supported by independent educational grant from Amarin Pharma, Inc.

  • Provider

              

Facebook Comments

Sign up for the Medtelligence newsletters.
Comprehensive Cardiology Education.

Better education for a better you.

* Required
Optional
Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free